State of New Jersey Common Pension Fund D Sells 741 Shares of Chemed Co. (NYSE:CHE)

State of New Jersey Common Pension Fund D lessened its position in shares of Chemed Co. (NYSE:CHE) by 14.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,519 shares of the company’s stock after selling 741 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Chemed were worth $2,716,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. GAMMA Investing LLC increased its holdings in shares of Chemed by 34.4% in the second quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock worth $47,000 after purchasing an additional 22 shares during the period. American National Bank & Trust purchased a new position in Chemed during the third quarter worth about $61,000. EntryPoint Capital LLC raised its holdings in shares of Chemed by 14.0% in the 1st quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock valued at $94,000 after acquiring an additional 18 shares in the last quarter. Mather Group LLC. boosted its position in shares of Chemed by 60.5% during the 2nd quarter. Mather Group LLC. now owns 183 shares of the company’s stock valued at $99,000 after acquiring an additional 69 shares during the last quarter. Finally, Quarry LP grew its holdings in shares of Chemed by 721.7% during the second quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after purchasing an additional 166 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Stock Down 0.0 %

NYSE CHE opened at $565.37 on Thursday. The stock’s 50-day simple moving average is $580.85 and its two-hundred day simple moving average is $565.47. Chemed Co. has a twelve month low of $523.33 and a twelve month high of $654.62. The company has a market capitalization of $8.51 billion, a price-to-earnings ratio of 28.57, a PEG ratio of 2.40 and a beta of 0.46.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the business posted $5.32 earnings per share. On average, equities analysts expect that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. Chemed’s dividend payout ratio (DPR) is 10.11%.

Analyst Ratings Changes

Separately, Royal Bank of Canada dropped their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $598.81, for a total value of $1,197,620.00. Following the transaction, the chief executive officer now owns 103,735 shares in the company, valued at approximately $62,117,555.35. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director George J. Walsh III sold 200 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares of the company’s stock, valued at approximately $1,991,615.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the sale, the chief executive officer now directly owns 103,735 shares in the company, valued at $62,117,555.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,144 shares of company stock valued at $3,002,419. Insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.